文献速递皮肤肿瘤

10%氨基乙酰丙酸凝胶红光光动力治疗浅表性基底细胞癌的III期随机对照研究

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.
PubMed 文献 · J Am Acad Dermatol · 2025-08-20

这项在美国21个中心开展的随机、双盲、载体对照III期研究纳入187例初治浅表性基底细胞癌患者,比较10%氨基乙酰丙酸凝胶红光光动力治疗与载体的疗效和安全性。结果显示10%氨基乙酰丙酸凝胶的组织学清除率为75.9%,显著高于载体的19.0%(P<.0001),临床清除率为83.4%对21.4%(P<.0001),且安全性良好、美观评价积极。

要点

  • 10%氨基乙酰丙酸凝胶光动力治疗浅表性基底细胞癌组织学清除率75.9%,显著优于载体19.0%。
  • 临床清除率83.4%对21.4%,差异具有统计学意义(P<.0001)。
  • 88.1%受试者美观评价为很好或好,安全性无新发不良事件。

核心结论

  • 10%氨基乙酰丙酸凝胶红光光动力治疗浅表性基底细胞癌的清除率显著高于载体,安全性良好且美观结果积极。

研究设计与样本

  • 随机、双盲、载体对照、关键性III期研究,在美国21个中心开展。
  • 纳入187例初治浅表性基底细胞癌患者,145例接受10%氨基乙酰丙酸凝胶光动力治疗,42例接受载体治疗。
  • 治疗方案为1-2个光动力治疗周期(每周期2次光动力治疗),末次周期开始后12周进行临床和组织学评估。

主要发现

  • 组织学清除率:10%氨基乙酰丙酸凝胶组75.9%,载体组19.0%(P<.0001)。
  • 临床清除率:10%氨基乙酰丙酸凝胶组83.4%,载体组21.4%(P<.0001)。
  • 88.1%接受10%氨基乙酰丙酸凝胶治疗的受试者将美观结果评价为很好或好。
  • 未发生此前未知的不良事件。

关键数值与推荐

  • 组织学清除率75.9%对19.0%(P<.0001)。
  • 临床清除率83.4%对21.4%(P<.0001)。
  • 美观评价很好或好的比例为88.1%。

临床怎么用

  • 10%氨基乙酰丙酸凝胶红光光动力治疗可作为浅表性基底细胞癌的非侵入性治疗选择,兼顾疗效与美观。

局限性

  • 面部/头皮病变的受试者较少。
  • 60个月随访仍在进行中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical procedures remain the gold standard for treating basal cell carcinoma (BCC), although commonly associated with cosmetic defects. The demand for noninvasive alternatives remains high. OBJECTIVE: To determine efficacy and safety of red light photodynamic therapy (PDT) with 10% 5-aminolevulinic acid (ALA) gel vs vehicle for treatment of superficial BCC. METHODS: This randomized, double-blind, vehicle-controlled, pivotal phase III study was conducted at 21 centers in the US. Eligible participants had ≥1 naïve superficial BCC and received 1-2 PDT cycles (2 PDTs each cycle) followed by clinical and histological assessment 12 weeks after start of the last PDT cycle. RESULTS: Of 187 randomized participants, 145 received PDT with 10% ALA gel and 42 with vehicle. Histological clearance was 75.9% with 10% ALA gel vs 19.0% with vehicle (P < .0001). Clinical clearance was 83.4% with 10% ALA gel vs 21.4% with vehicle (P < .0001). A total of 88.1% of participants treated with 10% ALA gel rated the esthetic outcome as very good or good. No previously unknown adverse events occurred. LIMITATIONS: Few participants with lesions on face/scalp; to date, a 60-month follow-up is still ongoing. CONCLUSION: 10% ALA gel showed significantly higher clearance rates than vehicle with unproblematic safety and positive esthetic outcome.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Schlesinger T, Chapman MS, Tu JH, et al. Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study. J Am Acad Dermatol. 2025. PMID: 40846240. doi:10.1016/j.jaad.2025.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。